Literature DB >> 7022832

Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia.

R P Warren, R Storb, P L Weiden, P J Su, E D Thomas.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7022832

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients.

Authors:  Patricia A Taylor; Michael J Ehrhardt; Matthew M Roforth; Jessica M Swedin; Angela Panoskaltsis-Mortari; Jonathan S Serody; Bruce R Blazar
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

2.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Authors:  Stephanie B Tsai; Hongtao Liu; Tsiporah Shore; Yun Fan; Michael Bishop; Melissa M Cushing; Usama Gergis; Lucy Godley; Justin Kline; Richard A Larson; Guadalupe Martinez; Sebastian Mayer; Olatoyosi Odenike; Wendy Stock; Amittha Wickrema; Koen van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-19       Impact factor: 5.742

Review 3.  Graft failure after allogeneic hematopoietic cell transplantation.

Authors:  Jonas Mattsson; Olle Ringdén; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 4.  The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

Authors:  Stefan O Ciurea; Kai Cao; Marcelo Fernandez-Vina; Piyanuch Kongtim; Monzr Al Malki; Ephraim Fuchs; Leo Luznik; Xiao-Jun Huang; Fabio Ciceri; Franco Locatelli; Franco Aversa; Luca Castagna; Andrea Bacigalupo; Massimo Martelli; Didier Blaise; Rupert Handgretinger; Denis-Claude Roy; Paul O'Donnell; Asad Bashey; Hillard M Lazarus; Karen Ballen; Bipin N Savani; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2018-01-15       Impact factor: 5.483

5.  HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.

Authors:  Kanwaldeep K Mallhi; Meera A Srikanthan; Kelsey K Baker; Haydar A Frangoul; Troy R Torgerson; Aleksandra Petrovic; Amy E Geddis; Paul A Carpenter; K Scott Baker; Brenda M Sandmaier; Monica S Thakar; Suzanne Skoda-Smith; Hans-Peter Kiem; Rainer Storb; Ann E Woolfrey; Lauri M Burroughs
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-28       Impact factor: 5.742

6.  A glow of HLA typing in organ transplantation.

Authors:  Batool Mutar Mahdi
Journal:  Clin Transl Med       Date:  2013-02-23

7.  Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.

Authors:  R F Olsson; B R Logan; S Chaudhury; X Zhu; G Akpek; B J Bolwell; C N Bredeson; C C Dvorak; V Gupta; V T Ho; H M Lazarus; D I Marks; O T H Ringdén; M C Pasquini; J R Schriber; K R Cooke
Journal:  Leukemia       Date:  2015-03-16       Impact factor: 11.528

Review 8.  Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation.

Authors:  Piyanuch Kongtim; Kai Cao; Stefan O Ciurea
Journal:  Adv Hematol       Date:  2016-01-24

9.  The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors.

Authors:  Anna Koclega; Miroslaw Markiewicz; Urszula Siekiera; Alicja Dobrowolska; Mizia Sylwia; Monika Dzierzak-Mietla; Patrycja Zielinska; Malgorzata Sobczyk Kruszelnicka; Andrzej Lange; Slawomira Kyrcz-Krzemien
Journal:  Bone Marrow Res       Date:  2012-10-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.